Rising pervasiveness of cancer across different regions of the world and subsequent number of fatalities are prompting the adoption of tissue processor equipment, finds the report. As per a revelation by the American Cancer Society and National Center for Health Statistics, approximately 1,688,780 cases of cancer were recorded in the year 2017. Alarming figures as such is consistently driving the need for development of efficient and constructive diagnostic equipment, with tissue processor equipment being a prominent one.
Burgeoning Investments on Healthcare Services to Stimulate High Adoption
Moreover, a rising geriatric population is creating an unabated demand for novel technologies in terms of diagnosis and treatment of chronic diseases, spurring the growth of tissue processor equipment market. According to the report, tissue processor equipment are witnessing high demand on account of creation of tissue samples for analysis, yet in an efficient and seamless way. Mostly being a single unit device, a tissue processor equipment is being actively sought-after, by virtue of its competency of accommodating multiple processing techniques as per diverse needs.
According to the report, the per capita expenditure on healthcare services is on a rise and is a key macro factor pushing growth of tissue processor equipment market. The will as well as capacity of individuals to spend on health and wellness has been identified as a key factor leading to an incremental growth of medical and healthcare industry. This, in turn, is poised to trigger the demand for tissue processor equipment market and provide the much-needed fillip to the market growth.
The report also associates the susceptibility to chronic disorders with the changing lifestyles. With the rising incidence of such diseases, the demand for laboratory instruments is also likely to accentuate, with tissue processors being no exception. As per the report, mushrooming number of hospitals and pathology laboratories is triggering the use of tissue processors to cater to the increasing demand for diagnostic and therapeutic services, creating favorable circumstances for growth of tissue processor equipment market.
Small Volume Tissue Processors Segment to Carry Promising Aspects
Manufacturers of tissue processor equipment are vying to offer tissue processors with minimum turnaround and maximum care. With the rising customer needs for enhanced quality and throughput on a simultaneous basis, the manufacturers are developing equipment with built-in quality and high-scale reliability. For instance, Leica Biosystems, a leading manufacturer, developed ‘HistoCore PELORIS 3 Premium Tissue Processor’ as a latest addition to its exclusive product line. This product was one-of-its-kind with top-notch features, while delivering high performance and an enhanced user experience.
As per the report, the small volume tissue processors segment reflects a substantial market standing and is likely to incur high revenues, followed by medium volume tissue processors. According to the report, the growth and expansion of tissue processor equipment market worldwide is directly proportional to the rising adoption of tissue processors with an aim of upgrading the lab efficiency.
North America continues to offer stellar opportunities for the market players of tissue processor equipment, backed by a robust healthcare infrastructure. In addition to that, Asia-Pacific also remains a lucrative region from an investment-making angle, with China anticipated to record an exponential growth owing to rising prevalence of cancer.